XML 58 R41.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Components of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Research credits $ 612,000 $ 574,000
Capitalized research and development 844,000
Stock-based compensation 1,631,000 2,137,000
Net operating loss carryforwards 8,601,000 8,135,000
Total deferred tax assets 11,688,000 10,846,000
Valuation allowance (11,688,000) (10,846,000)
Net deferred tax assets